McKesson Corporation (mck)
MCK Financials
| Trailing P/E | 22.83 |
| Forward P/E | 17.25 |
| Price/Sales | 0.25 |
| Price/Book | -48.14 |
| Market cap | $101.59B |
| Avg volume | 1168248.0 |
| Shares outstanding | 116590363.0 |
McKesson Corporation FAQ
What does McKesson Corporation (MCK) do?
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes bra…
What is MCK's P/E ratio?
McKesson Corporation has a trailing P/E of 22.83× based on publicly available market data.
Does MCK pay a dividend?
Indicated dividend yield: 0.5%. Confirm ex-dates and payout history in Vest Terminal.
What sector is MCK in?
McKesson Corporation is classified in Healthcare (Medical Distribution) on NYQ.
What is MCK's market capitalization?
Approximate market cap: $101.59B.
What are the main risks for MCK?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of MCK?
Potential positives include revenue growth of 6.0% year-over-year, earnings growth of 37.2% year-over-year.
Where can I get analyst estimates for MCK?
Consensus estimates, price targets, and detailed analyst data for McKesson Corporation are available to Professional subscribers in Vest Terminal — not on this public summary page.